Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ADAM8 Monoclonal Antibody (3B10D7)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA548360
Description
ADAM8 Monoclonal Antibody for Western Blot, ICC/IF, Flow, ELISA
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene may be involved in cell adhesion during neurodegeneration, and it is thought to be a target for allergic respiratory diseases, including asthma. Alternative splicing results in multiple transcript variants.
Specifications
ADAM8 | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
P78325 | |
ADAM8 | |
Purified recombinant fragment of human CD156 (AA: extra 17-156) expressed in E. Coli. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG2a |
ELISA, Flow Cytometry, Western Blot, Immunocytochemistry, Western Blot | |
3B10D7 | |
Unconjugated | |
ADAM8 | |
a disintegrin and metallopeptidase domain 8; a disintegrin and metalloproteinase; a disintegrin and metalloproteinase domain 8; ADAM; ADAM 8; ADAM metallopeptidase domain 8; Adam8; ADAMs; CD156; CD156a; Cell surface antigen MS2; disintegrin and metalloproteinase domain-containing protein 8; E430039A18Rik; human leukocyte differentiation antigen; Macrophage cysteine-rich glycoprotein; metalloendopeptidases; MGC134985; MS2; RGD1566394 | |
Mouse | |
Protein G | |
RUO | |
101 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction